Products for Research Use Only
RegisterLogin

Pinatuzumab vedotin

CAT: 0804-HY-141602-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-141602-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Pinatuzumab vedotin, an antibody-drug conjugate (ADC), is a CD22 humanized monoclonal antibody Pinatuzumab conjugated to VcMMAE (HY-15575). Pinatuzumab vedotin has antitumor activities[1].
CAS Number
1313706-14-7
Product Name Alternative
Anti-CD22-vc-MMAE; DCDT2980S
UNSPSC
12352211
Target
Antibody-Drug Conjugates (ADCs) ; CD22; Microtubule/Tubulin
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
98.25
Smiles
[Pinatuzumabvedotin]
References & Citations
[1]Ranjana H Advani, et al. Phase I Study of the Anti-CD22 Antibody–Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. Clinical Trial Clin Cancer Res. 2017 Mar 1;23 (5) :1167-1176.|[2]Yip, V., et al., (2024) . Monomethyl auristatin E (MMAE), a payload for multiple antibody drug conjugates (ADCs), demonstrates differential red blood cell partitioning across human and animal species. Xenobiotica; the fate of foreign compounds in biological systems, 54 (8), 511–520.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P99230-01Pinatuzumab
HY-P99662-01Indusatumab vedotin
HY-132253-01Polatuzumab vedotin
HY-P9985-01Disitamab vedotin
HY-145627-01Ozuriftamab vedotin
HY-164992-01Trastuzumab vedotin
HY-152963-01Tisotumab vedotin
HY-145622-01Mecbotamab vedotin
HY-P99595-01Sirtratumab vedotin
HY-P99657Iladatuzumab vedotin

Alternative Products

CatalogName
C00976-1mgPinatuzumab vedotin
MBS1581193-01Pinatuzumab vedotin (ADC)
GTR18401359-01Pinatuzumab vedotin Antibody
592115Pinatuzumab Vedotin (CD22)
KBI1556KRIBIOLISA™ Pinatuzumab Vedotin ELISA
ICH5093V-0.1mgPinatuzumab Vedotin Biosimilar - Research Grade
10-588Pinatuzumab Vedotin (CD22) - Research Grade Biosimilar
F1129-50Anti-Siglec-2/CD22 Antibody (Pinatuzumab vedotin)
GTR18117326Pinatuzumab Vedotin (CD22) - Research Grade Biosimilar Antibody
BIO0877SM-1mgAnti-human Siglec-2 / CD22 (Pinatuzumab vedotin Biosimilar)

Popular Products